Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
Open Access
- 28 May 2012
- journal article
- review article
- Published by Hindawi Limited in International Journal of Hepatology
- Vol. 2012, 1-16
Abstract
Liver cancer is the fifth most common cancer in men and the seventh in women. During the past 20 years, the incidence of HCC has tripled while the 5-year survival rate has remained below 12%. The presence of circulating tumor cells (CTC) reflects the aggressiveness nature of a tumor. Many attempts have been made to develop assays that reliably detect and enumerate the CTC during the development of the HCC. In this case, the challenges are (1) there are few markers specific to the HCC (tumor cells versus nontumor cells) and (2) they can be used to quantify the number of CTC in the bloodstream. Another technical challenge consists of finding few CTC mixed with million leukocytes and billion erythrocytes. CTC detection and identification can be used to estimate prognosis and may serve as an early marker to assess antitumor activity of treatment. CTC can also be used to predict progression-free survival and overall survival. CTC are an interesting source of biological information in order to understand dissemination, drug resistance, and treatment-induced cell death. Our aim is to review and analyze the different new methods existing to detect, enumerate, and characterize the CTC in the peripheral circulation of patients with HCC.Keywords
This publication has 185 references indexed in Scilit:
- MicroRNAs and liver diseaseTranslational Research, 2011
- Alpha-fetoprotein-thymidine kinase–luciferase knockin mice: A novel model for dual modality longitudinal imaging of tumorigenesis in liverJournal of Hepatology, 2010
- Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent AdvancementsSeminars in Liver Disease, 2010
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- Circulating endothelial cells in oncology: pitfalls and promisesBritish Journal of Cancer, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerNew England Journal of Medicine, 2005
- Standardized quantification of circulating peripheral tumor cells from lung and breast cancerClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Classification of isolated tumor cells and micrometastasisCancer, 1999
- Multistep Nature of Metastatic InefficiencyThe American Journal of Pathology, 1998